Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2024 · research · ASAP CRN Competitive Renewal Opportunity
Redefining the Pathophysiological Mechanisms of Parkinson’s Disease in the Context of Heterogeneous Neuronsl Subtypes in the Substantia Nigr
Rajeshwar Awatramani · Northwestern University
2024 · research · Measuring Alpha-Synuclein in Extracellular Vesicles
Measuring Alpha-synuclein in Extracellular Vesicles: A Biomarker for the Diagnosis and Staging of Neuronal α-Synuclein Diseases
Erez Eitan · Neurodex
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Development of Selective Ion Channel Inhibitors as a Disease-modifying Therapy for Parkinson’s Disease
Thomas Stephen Otis · Lario Therapeutics
2024 · research · Measuring Alpha-Synuclein in Extracellular Vesicles
Development of an Alpha-synuclein Blood Biomarker for Clinical Use
George Tofaris · University of Oxford
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Study of Multiple Air Pollutants in Parkinson’s Disease (MAP-PD)
Susan Searles Nielsen · Washington University in St. Louis
2024 · research · Research Grant
Chronos-PD Pilot: Analyzing Plasma from Donors Who Develop Parkinson’s Disease Later in Life
Benoit Lehallier · Alkahest, Inc.
2024 · research · iPSC Phenotyping Environmental Exposure Program
Use of a Stem-cell-based Platform to Screen for Environmental Factors in Parkinson’s Disease
Edward A. Fon · McGill University
2024 · research · Research Grant
(SUPPLEMENT) Investigation of Small Molecules for Rescuing Lysosomal and GBA1 Deficiencies in GBA-associated Parkinson’s Disease
Marlene A. Jacobson · Temple University
2024 · research · Research Grant
Determining Optimal Cognitive Measures and Clinical Trial Endpoints in Lewy Body Disorders
Jennifer G. Goldman · Jpg Enterprises Llc
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Investigation of a Novel Therapeutic Approach for Non-motor Symptoms of Parkinson’s Disease
Kohei Shimada · Gexval Inc.
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Development of a First-in-class Inhibitor of the “Mitochondrial Permeability Transition Pore” as a Novel Disease-modifying Treatment for Parkinson’s Disease
Neil Derek Miller · Nrg Therapeutics Ltd
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Therapeutic Development of Novel STING Inhibitors to Treat Parkinson's Disease Neuroinflammation
John Streiff · Inflammanova Rx, Llc
2024 · research · Research Grant
Discovery of PET Tracers for Measuring Alpha-synuclein
Helen Mitchell · Merck & Co., Inc.
2024 · research · ASAP CRN Competitive Renewal Opportunity
Understanding and Manipulating Cellular and Circuit-level Vulnerability to Neurodegeneration in Parkinson’s Disease
Thomas Biederer · Yale University
2024 · research · Research Grant
Virtual Screening and Biochemical Confirmation of Small Molecule Activators of ATP10B
Peter Vangheluwe · KU Leuven
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biomarkers
Investigating the Early Events in Parkinson’s Disease Pathobiology through Longitudinal Evaluation of Asymptomatic Carriers of Alpha-synuclein Mutations
Leonidas Stefanis · University Of Athens Medical School And Biomedical Research Foundation Of The Academy Of Athens
2024 · research · Research Grant
Measurement of Phosphorylated Alpha-synuclein in Skin Biopsies as a Prospective Biomarker for Parkinson’s Disease
Roy Freeman · Harvard University
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
A Novel Brain-penetrating Antibody for Treating Parkinson’s Disease
Mattias E. Ivarsson · Salvina Therapeutics Inc.
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
A Novel Approach to Activating Glucosylceramidase in People with Parkinson’s Disease
Gilles Hugues Tapolsky · Bexion Pharmaceuticals
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biomarkers
Development and Validation of a Sensitive Method for Measuring PRKN
Fabienne C. Fiesel · Mayo Clinic
2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology
Strengthening Evidence-based Regulatory Decision-making to Address the Impact of Pesticides on Parkinson's Disease Risk
Tracey Woodruff · The Regents Of The University Of California San Francisco
2024 · research · ASAP CRN Competitive Renewal Opportunity
Investigating How Alpha-synuclein-rich Neurons in Olfactory Circuits Respond to Environmental Triggers at the Initiation of Parkinson Disease
Michael G. Schlossmacher · Ottawa Hospital
2024 · research · 2022: Accelerated Therapeutics Program
(SUPPLEMENT) Small Molecule Mitochondrial Modulators for the Treatment of Parkinson's Disease
Amy Ripka · Lucy Therapeutics
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Use of an Angiotensin-(1-7) Glycopeptide, to Treat Dementia in Parkinson's Disease
Torsten Falk · University of Arizona
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Development of Brain-penetrant TrkB Agonist Antibody for Parkinson’s Disease
Pawel Stocki · Ossianix
2024 · research · Accelerating Biological Understanding and Therapeutic Translation For Parkinson’s Disease- Biology
Establishing a Cohort of Carriers with ATP13A2 Mutations for Clinical and Biomarker Analysis
Peter Vangheluwe · KU Leuven
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Phase 2a Clinical Study of HBI-002 in Parkinson’s Disease
Edward Gomperts · Hillhurst Biopharmaceuticals, Inc.
2024 · research · Research Grant
Funding Support 2024-2026 for Critical Path Clinical Outcome Assessment Experts
Cheryl D. Coon · Critical Path Institute
2024 · research · 2022: Accelerated Therapeutics Program
(SUPPLEMENT) Innovative Therapies for Parkinson’s Disease Through a Novel, Unexploited Gene Expression Mechanism Rooted in Human Genetics Enabling a Precision-medicine Approach
Roman Urfer · Selonterra, Inc.
2024 · research · Parkinson’s Disease Therapeutics Pipeline Program
Investigating Oxygen Limitation (Hypoxia) as a Novel Treatment for Parkinson’s Disease
Bastiaan R. Bloem · Radboud University Medical Center
2024 · research · ASAP 2020
Parkinson5D: Deconstructing Disease Mechanisms Across Cells, Space and Disease Progression
Clemens Scherzer · Yale University
2024 · research · Freezing of Gait
Adaptive Cortical Neuromodulation Using a Brain-machine Interface to Treat Freezing of Gait in Parkinson’s Disease
Alfonso Fasano · University Of Toronto/krembil Research Institute/university Health Network
2024 · research · Freezing of Gait
Use of Soft Robotic Apparel to Prevent Freezing of Gait in Parkinson’s Disease
Terry Ellis · Boston University
2024 · research · Research Grant
Developing an Open-access Repository of High-quality Digital Measurement Tools for Use in Parkinson’s Disease Research and Care
Jessie Patricia Bakker · Digital Medicine Society
2024 · research · iPSC Phenotyping Environmental Exposure Program
Using Stem-cell Derived Brain-chip Technologies to Evaluate the Contributions of Environmental Toxins to Parkinson’s Disease
Aurelie De Rus Jacquet · Université Laval
2024 · research · Freezing of Gait
TURN-IT: A Novel Intervention to Improve Turning in People with PD and Freezing of Gait
Martina Mancini · Oregon Health & Science University
2024 · research · ASAP CRN Competitive Renewal Opportunity
Studying the Circuit Dysfunction Underlying Motor and Sleep Deficits in a Progressive Preclinical Model of Parkinson’s Disease
D. James Surmeier · Northwestern University
2024 · research · iPSC Phenotyping Environmental Exposure Program
Phenotyping Environmental Exposure to Long-lasting Chemicals, Nanoplastics and Pesticides in iPSC Dopaminergic Neurons and Glia
Lezanne Ooi · University of Wollongong
2024 · research · ASAP CRN Competitive Renewal Opportunity
Mapping the LRRK2 Signaling Pathway and Uncovering Its Interplay with Other Molecular Components of Parkinson’s Disease
Dario Alessi · University of Dundee
2024 · research · Research Grant
Validation of Functional Staging of Parkinson’s Disease Using the Critical Path for Parkinson’s (CPP) Integrated Parkinson’s Database
Connie Marras · Toronto Western Hospital Movement Disorders Centre